Marília Brito Gomes

Universidade do Estado do Rio de Janeiro

Also affiliated with Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER”.

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER

BMC Endocrine Disorders(2022)10.1186/s12902-022-01026-2

N/A

0DataRank · unranked

81 citations

Fengming Tang, Andrew Cooper, Hungta Chen, Marília Brito Gomes, Wolfgang Rathmann +6 more

Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study

Indian Heart Journal(2022)10.1016/j.ihj.2022.07.008

N/A

0DataRank · unranked

2 citations

Hungta Chen, Fengming Tang, Paul Chan, Andrew Cooper, Marília Brito Gomes +11 more